Physician

Asif Saeed Kazmi, M.D.

According to 2025 Medicare claims, Asif Kazmi, M.D. (NPI: 1750501623) practices internal medicine in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from Crittenden, AR. This provider's primary affiliated billing organization is MID-SOUTH RENAL CLINIC, PLC (NPI: 1093724346; TIN: 710843279) and primary practice location at 72364-9027.

Kazmi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 360 traditional Medicare patients, billed 1,499 HCPCS/CPT codes, and received $206,784 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 7,069 prescription claims across 646 beneficiaries totaling $1,797,141 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2022 DME data shows 49 claims. Open Payments data shows 59 records totaling $1,521. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $442 and ending at $295.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	682	4,798	$333,801
2016	675	3,980	$298,326
2017	597	3,854	$297,745
2018	699	4,302	$341,473
2019	716	4,479	$382,431
2020	649	4,044	$379,104
2021	506	3,057	$345,250
2022	376	1,858	$258,597
2023	356	1,491	$210,475
2024	360	1,499	$206,784

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	271	3,193	$1,159,755
2016	251	2,906	$1,358,633
2017	240	2,620	$1,318,482
2018	280	2,329	$612,773
2019	312	2,167	$339,774
2020	339	2,550	$448,296
2021	430	3,246	$737,368
2022	508	4,828	$1,022,285
2023	582	6,181	$1,326,604
2024	646	7,069	$1,797,141

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	120	$13,716
2016	N/R	133	$14,171
2017	N/R	112	$10,820
2018	N/R	202	$10,580
2019	N/R	148	$10,543
2020	N/R	116	$7,898
2021	N/R	62	$2,639
2022	N/R	49	$2,978
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	65	226	$276
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	67	310	$219
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	45	49	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	150	392	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	79	272	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	150	4,942	$532,069
Xphozah	Tenapanor Hcl	83	4,800	$475,773
Farxiga	Dapagliflozin Propanediol	187	9,680	$180,913
Jardiance	Empagliflozin	153	6,946	$133,066
Kerendia	Finerenone	64	3,160	$68,476

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	59	$1,521	Ardelyx, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asif Saeed Kazmi, M.D.?

Tedicare shows public-source Medicare data for Asif Saeed Kazmi, M.D. (NPI 1750501623), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asif Saeed Kazmi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Asif Saeed Kazmi, M.D.?

Asif Saeed Kazmi, M.D. is linked to MID-SOUTH RENAL CLINIC, PLC (billing NPI 1093724346) in the available physician profile data.

Does Asif Saeed Kazmi, M.D. have Open Payments data?

Asif Saeed Kazmi, M.D. has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.